Gene · 10521
NIH grants1,197
NIH grants whose papers are about the gene, through NIH's grant-paper links.
421 to 440 of 1,197
Download this page as JSON| Grant | Title | DDX17 papers | Newest fiscal year |
|---|---|---|---|
| R01GM123314 | Mapping RNA protein interaction networks in the human genome | 1 | 2021 |
| R01GM124494 | Post-translational modifications in RORgt-dependent immune cell functions | 1 | 2021 |
| R01GM125196 | Regulation of genomic stability by ORC | 1 | 2021 |
| R01HL057244 | Lysosome Regulation of Exosome Release and Function in Arterial Smooth Muscle | 1 | 2021 |
| R01LM012535 | Integrating Neuroimaging, Multi-omics, and Clinical Data in Complex Disease | 1 | 2021 |
| R01NS079697 | Tumor cell and microenvironment changes causing antiangiogenic therapy resistance | 1 | 2021 |
| R01NS095867 | Directed Evolution of Novel AAV Capsis for Global CNS Delivery in Rodents and Primates | 1 | 2021 |
| R21AG065748 | Monoalleleic autosomal spreading of a novel family of nucleolus-localized ncRNAs | 1 | 2021 |
| R21AI144433 | Influenza host specific glycan motif identification through systems biology | 1 | 2021 |
| R21AI151882 | Elucidating the functional roles of long noncoding RNAs in Chikungunya virus infection | 1 | 2021 |
| R35GM124736 | Molecular mechanisms of chromatin and epigenetic regulation | 1 | 2021 |
| R42HL145930 | Novel Therapeutic Antibody Targeting of Extracellular NAMPT in Ventilator-Induced Lung Injury (VILI) | 1 | 2021 |
| R56AI158314 | Role and Mitigation of Inflammasomes and Inflammation During COVID-19 | 1 | 2021 |
| T32GM008555 | University Training Program in Biomolecular and Tissue Engineering | 1 | 2021 |
| U01CA214125 | MICROSCALED PROTEOGENOMICS FOR CANCER CLINICAL TRIALS | 1 | 2021 |
| U41HG009889 | A Comprehensive Functional Map of Human Protein-RNA Interactions | 1 | 2021 |
| U54AI150472 | HIV Interactions In Viral Evolution | 1 | 2021 |
| UG3TR002968 | Network-Based Novel Therapeutics in Colorectal Cancers | 1 | 2021 |
| ZIAES046008 | Genetic Susceptibility To Carcinogens | 1 | 2021 |
| ZIAHD001902 | SUMO family Ubiquitin-like Modifiers In Higher Eukaryotes | 1 | 2021 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10521/grants?page=22